News
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
NuWays AG releases research on SYNBIOTIC SE, recommending BUY at a target price of EUR 5.50. Recent strategic changes include additional equity, portfolio cleanup, and a new strategic investor. Download the full report at the provided link -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
SYNBIOTIC strengthens its presence at international events and emphasizes the importance of natural full-spectrum approaches to CBD products. Recent research confirms the potential of the entourage effect -